Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
5 minute read
  • Biotech
  • Commodities
  • Dividends
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Legal
  • Markets
  • Media
  • Movers
  • News
  • Tech
  • Top Stories
  • Trading Ideas

Tesla’s Autopilot Draws Regulatory Scrutiny, Volkswagen Expects Supply Crisis To Continue, TikTok To Launch Standalone Gaming Channel: Top Stories Friday, Oct. 28

By Vandana Singh
October 28, 8:58 AM
Wall Street Journal Tesla's Autopilot Draws Regulatory Ire From DoJ and SEC

AAL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

National Institutes of Health’s Long COVID Initiative To Assess Pfizer’s Antiviral Pill As Potential Treatment

By Vandana Singh
October 28, 8:39 AM
The National Institutes of Health's $1 billion RECOVER Initiative has decided to study Pfizer Inc's (NYSE: PFE) antiviral drug Paxlovid as a potential treatment for long COVID.

PFE

Read More
1 minute read
  • Biotech
  • General
  • Media
  • News

Justice Department Launches Probe Into Poultry Companies’ Payment Practices: Report

By Shivani Kumaresan
October 28, 6:24 AM
The U.S. Justice Department has launched an investigation into the method of payments made to chicken farmers by poultry companies.

PPC

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Small Cap

Analyst Sees Market Potential For Arcellx Multiple Myeloma Candidate, Sees 50% Upside In Stock

By Vandana Singh
October 27, 2:37 PM
Needham initiated coverage on Arcellx Inc (NASDAQ:ACLX) with a Buy rating and a price target of $31. Arcellx’s lead program and main…

ACLX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca’s Ultomiris Showed Zero Relapses In Patients With Chronic Disorder Of Brain, Spinal Cord

By Vandana Singh
October 27, 10:44 AM
AstraZeneca Plc (NASDAQ:AZN) posted detailed results from the Phase 3 CHAMPION-NMOSD trial of Ultomiris (ravulizumab) For neuromyelitis optica spectrum disorder (NMOSD). NMOSD…

AZN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Legal
  • News

Pfizer Says Its Minority Fellowship Program Serves Public Interest, In Defending Lawsuit

By Vandana Singh
October 27, 9:20 AM
Pfizer Inc (NYSE: PFE) came forward to defend a lawsuit by a group of medical professionals claiming that the fellowship program illegally excludes whites and Asian Americans.

PFE

Read More
4 minute read
  • Biotech
  • General
  • News

Lexaria’s Human Clinical HYPER-H21-4 Study

By Benzinga Newsdesk
October 27, 9:18 AM
HYPER-H21-4 using DehydraTECH-CBD evidenced: Exceptional safety and tolerability Statistically significant lowering of 24-hour ambulatory blood pressure ("BP") BP lowered for the entire 5-week study

LEXX

Read More
2 minute read
  • Biotech
  • General
  • News

Stevanato Group And DWK Life Sciences Sign Non-Exclusive Distribution Agreement For EZ-fill Platform Products

By Benzinga Newsdesk
October 27, 8:06 AM
Stevanato Group aims to expand distribution of EZ-fill® whose proven advantages have turned its processing technology into an industry standard for Ready-To-Use products. Stevanato Group S.p.A. (NYSE:STVN), a

STVN

Read More
4 minute read
  • Biotech
  • General
  • News

Invitae Announces Partnership For Real-World Data Sharing To Inform Rare Cancer Research

By Benzinga Newsdesk
October 27, 7:36 AM
– Using Invitae's Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a rare cancer to drive further research – –

AZN

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • News

Soligenix Invited To Submit BARDA Contract Proposal For Development Of Thermostabilized Subunit Vaccines For Sudan Ebola And Marburg Viruses

By Benzinga Newsdesk
October 27, 7:33 AM
Emerging infectious diseases where no protective vaccines are currently available SuVax™ targets Sudan ebolavirus, origin of a current disease outbreak in Uganda

SNGX

Posts pagination

Previous 1 … 645 646 647 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service